PHILADELPHIA CHROMOSOME NEGATIVE ALL
Clinical trials for PHILADELPHIA CHROMOSOME NEGATIVE ALL explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME NEGATIVE ALL trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME NEGATIVE ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo offers hope for tough leukemia cases
Disease control Recruiting nowThis study tests a new drug combination for people with acute lymphoblastic leukemia (ALL) that has come back or not responded to standard treatment. The approach adds a low dose of venetoclax (a targeted drug) and itraconazole (to boost its effect) to a standard chemotherapy reg…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New combo therapy aims to boost remission in adult leukemia patients
Disease control Recruiting nowThis study tests whether adding CAR-T cell therapy after standard chemotherapy can help adults newly diagnosed with a type of leukemia (Ph-negative B-ALL) achieve deeper remission and live longer. About 77 participants will receive the combination treatment. The goal is to reduce…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:01 UTC